W, L., X, S., H, L., & C, M. (2026). The CpG island methylator phenotype defines an immune-cold and therapy-resistant subtype of cutaneous melanoma. Frontiers in immunology, 17, 1821360. https://doi.org/10.3389/fimmu.2026.1821360
Chicago Style (17th ed.) CitationW, Lu, Sha X, Lei H, and Mao C. "The CpG Island Methylator Phenotype Defines an Immune-cold and Therapy-resistant Subtype of Cutaneous Melanoma." Frontiers in Immunology 17 (2026): 1821360. https://doi.org/10.3389/fimmu.2026.1821360.
MLA (9th ed.) CitationW, Lu, et al. "The CpG Island Methylator Phenotype Defines an Immune-cold and Therapy-resistant Subtype of Cutaneous Melanoma." Frontiers in Immunology, vol. 17, 2026, p. 1821360, https://doi.org/10.3389/fimmu.2026.1821360.
Warning: These citations may not always be 100% accurate.